UBS Group AG - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 160 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$2,144,000
+2002.0%
56,930
+849.1%
0.00%
Q4 2020$102,000
+436.8%
5,998
+41.8%
0.00%
Q3 2020$19,000
-94.7%
4,230
-92.8%
0.00%
Q2 2020$357,000
+643.8%
58,547
+178.6%
0.00%
Q1 2020$48,000
-79.5%
21,016
-58.8%
0.00%
Q4 2019$234,000
-49.4%
51,006
-57.2%
0.00%
Q3 2019$462,000
+3750.0%
119,213
+5636.9%
0.00%
Q2 2019$12,000
-69.2%
2,078
-27.2%
0.00%
Q1 2019$39,000
-95.8%
2,854
-97.1%
0.00%
Q4 2018$925,000
+683.9%
99,438
+1072.1%
0.00%
Q3 2018$118,000
+13.5%
8,484
+29.4%
0.00%
Q2 2018$104,000
-93.9%
6,557
-93.4%
0.00%
-100.0%
Q1 2018$1,695,000
+583.5%
98,653
+773.8%
0.00%
Q4 2017$248,000
-15.4%
11,290
+57.6%
0.00%
Q3 2017$293,000
+26.8%
7,164
-6.7%
0.00%
Q2 2017$231,000
+5.0%
7,676
+26.4%
0.00%
Q1 2017$220,000
-80.1%
6,072
-72.5%
0.00%
-100.0%
Q4 2016$1,105,000
+41.3%
22,058
+48.2%
0.00%
Q3 2016$782,000
+942.7%
14,888
+726.2%
0.00%
Q2 2016$75,000
+127.3%
1,802
+121.1%
0.00%
Q1 2016$33,000
-10.8%
815
-7.0%
0.00%
Q4 2015$37,000
+68.2%
876
-2.4%
0.00%
Q2 2015$22,0008980.00%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 115,500$2,531,0000.89%
AWM Investment Company, Inc. 150,000$3,288,0000.64%
BB BIOTECH AG 827,500$18,139,0000.51%
Virtus ETF Advisers LLC 17,371$381,0000.48%
Rock Springs Capital Management LP 425,000$9,316,0000.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 450,728$9,880,0000.39%
Telemetry Investments, L.L.C. 44,176$968,0000.37%
RTW INVESTMENTS, LP 100,377$2,200,0000.37%
Eventide Asset Management 315,000$6,905,0000.36%
ACUTA CAPITAL PARTNERS, LLC 52,500$1,151,0000.22%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders